JPH0740931B2 - Cell culture method - Google Patents

Cell culture method

Info

Publication number
JPH0740931B2
JPH0740931B2 JP61129419A JP12941986A JPH0740931B2 JP H0740931 B2 JPH0740931 B2 JP H0740931B2 JP 61129419 A JP61129419 A JP 61129419A JP 12941986 A JP12941986 A JP 12941986A JP H0740931 B2 JPH0740931 B2 JP H0740931B2
Authority
JP
Japan
Prior art keywords
hepatocytes
collagen
culture
cells
thin film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61129419A
Other languages
Japanese (ja)
Other versions
JPS62285781A (en
Inventor
勝利 吉里
憲一 佐々木
昇 山本
敏 高山
暉夫 宮田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Priority to JP61129419A priority Critical patent/JPH0740931B2/en
Publication of JPS62285781A publication Critical patent/JPS62285781A/en
Publication of JPH0740931B2 publication Critical patent/JPH0740931B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は細胞の培養法に関する。TECHNICAL FIELD The present invention relates to a method for culturing cells.

(従来の技術) 初代培養肝細胞は多彩な肝機能の解明のために用いられ
ている。このため、長期間培養する努力が払われ、比較
的長く培養維持する方法として、コラーゲン膜上、ニト
ロセルローズ・フィルター上、コラーゲン・ナイロンメ
ッシュ上、ラット肝組織より分離したバイオマトリック
ス上などで肝細胞を培養する方法が用いられているが必
ずしも成功していない。
(Prior Art) Primary cultured hepatocytes are used for elucidation of various liver functions. For this reason, efforts have been made to culture for a long period of time, and as a method of maintaining the culture for a relatively long period, hepatocytes on collagen membrane, nitrocellulose filter, collagen nylon mesh, biomatrix separated from rat liver tissue, etc. A method of cultivating C. is used but has not always been successful.

また、線維繊芽細胞をフィーダー(feeder)細胞として
何らかの成長因子および栄養の供給の役に利用するた
め、この細胞と初代肝細胞を混合して培養する方法(G.
Michalopoulos et al.:In Vitro 15,796(1979))も行
われている。
Also, in order to utilize fibroblasts as feeder cells to supply some growth factors and nutrients, a method in which these cells and primary hepatocytes are mixed and cultured (G.
Michalopoulos et al .: In Vitro 15 , 796 (1979)) has also been performed.

しかし、肝細胞以外の細胞と肝細胞を共に培養すると、
両者が混存し、また肝細胞以外の細胞が著るしく増殖す
るため、肝細胞自身の機能の解明が制限されるのが実情
であった。
However, when co-culturing cells other than hepatocytes and hepatocytes,
Since both of them coexist and cells other than hepatocytes proliferate markedly, the fact is that the elucidation of the functions of hepatocytes themselves is limited.

(問題点を解決するための手段) 上記の問題を解決するために本発明者は、X線を照射し
線維芽細胞の増殖を抑制すること、および透過性の高い
コラーゲン膜の片側に線維芽細胞をその反対側に肝細胞
をまいて両者を分離して培養する工夫を行って初代肝細
胞を長期間培養維持し得る方法、および、それらを組合
せた方法、を発明した。
(Means for Solving Problems) In order to solve the above problems, the present inventor irradiates X-rays to suppress the proliferation of fibroblasts, and the fibroblasts on one side of a highly permeable collagen membrane. A method was devised in which hepatocytes were spread on the opposite side of the cells and the cells were separated and cultured, whereby a method of maintaining primary hepatocytes in culture for a long period of time, and a method combining them were invented.

(構成) 本発明は、細胞に親和性を有する有孔性薄膜の一方の面
に線維芽細胞をまき、かつ他方の面に肝細胞をまいて培
養することを特徴とする細胞の培養法を提供するもので
ある。
(Structure) The present invention provides a method for culturing cells, which comprises culturing by plating fibroblasts on one surface of a porous thin film having an affinity for cells and hepatocytes on the other surface. It is provided.

初代肝細胞としては分離直後の肝細胞を用い、哺乳類、
例えばラット、マウス、モルモット、ハムスター、ウサ
ギ、イヌ、サル、ウシ、ウマ、ブタ、ヒツジ、ヤギ等お
よびヒト由来の肝細胞を利用する。
As the primary hepatocytes, hepatocytes immediately after separation were used, and
For example, hepatocytes derived from rat, mouse, guinea pig, hamster, rabbit, dog, monkey, cow, horse, pig, sheep, goat, etc. and human are used.

線維芽細胞としては3T3、肝由来の線維芽細胞、皮膚由
来の線維芽細胞等を用いることができる。
As the fibroblasts, 3T3, liver-derived fibroblasts, skin-derived fibroblasts and the like can be used.

X線照射は通常のX線照射装置によつて行えばよく、照
射量としては3000〜10000radの範囲が適当である。これ
は細胞が増殖能力を失うが生存し得る状態となることを
観察することによって適当量を決めることができる。
The X-ray irradiation may be performed by a normal X-ray irradiation device, and the irradiation amount is preferably in the range of 3,000 to 10,000 rad. This can be determined in an appropriate amount by observing that the cells lose their proliferative capacity but become viable.

細胞に親和性を有する有孔性薄膜とは、細胞がよく付着
し、その生存に悪影響を与えないこと、及び栄養分等を
適度に透過させる孔があるものであればよく、例えば、
コラーゲン(Exp.Cell Res.94,70(1975))、ニトロセ
ルロース(Exp.Cell Res.114,307(1978))、コラーゲ
ン・ナイロン(Proc.Natl,Acad.Sci.,USA,76,283(197
9))などを挙げることができ、特にコラーゲンが好ま
しい。
The porous thin film having an affinity for cells may be such that cells adhere well, do not adversely affect its survival, and have pores that allow nutrients to permeate appropriately, for example,
Collagen (Exp.Cell Res. 94, 70 ( 1975)), nitrocellulose (Exp.Cell Res. 114, 307 ( 1978)), collagen nylon (Proc.Natl, Acad.Sci., USA, 76, 283 ( 197
9)) and the like, and collagen is particularly preferable.

有孔性コラーゲン薄膜は、例えば、コラーゲン溶液(通
常0.3〜0.6%、pH2〜4.5)を疎水性プラスチック上で風
乾する等の方法でシート状にした後、塩類水溶液に浸漬
して線維化させ、これに紫外線照射する等してコラーゲ
ン線維に架橋を導入して製造することができる。
The porous collagen thin film is, for example, formed into a sheet by a method such as air-drying a collagen solution (usually 0.3 to 0.6%, pH 2 to 4.5) on a hydrophobic plastic, and then immersed in an aqueous salt solution to be fibrotic, It can be produced by introducing crosslinks into collagen fibers by irradiating this with ultraviolet rays.

コラーゲンとしては、熱可溶性コラーゲン、または、天
然コラーゲンを酸水溶液(酢酸、クエン酸、乳酸、塩酸
等)中で、プロテアーゼ(ペプシン等)で処理して、コ
ラーゲン分子末端のテロペプチドを除去すると同時に、
分子架橋を切断することによって得られるアテロコラー
ゲンであってもよい。
As collagen, heat-soluble collagen or natural collagen is treated with a protease (pepsin, etc.) in an aqueous acid solution (acetic acid, citric acid, lactic acid, hydrochloric acid, etc.) to remove telopeptides at the ends of collagen molecules,
It may be atelocollagen obtained by cleaving molecular crosslinks.

塩類水溶液に浸漬して線維化させる時の塩類水溶液とし
ては、pH5〜9の緩衝液、例えばリン酸緩衝液でよく、
生理食塩水等であっても良い。
As the salt aqueous solution when it is dipped in the salt aqueous solution to be fibrotic, a buffer solution having a pH of 5 to 9, for example, a phosphate buffer solution may be used.
It may be physiological saline or the like.

培養液としては、初代肝細胞に用い得るものであればよ
く、例えば、表皮細胞培養用に開発されたグリーンメデ
ィウム(文献後記)等がある。
Any culture medium may be used as long as it can be used for primary hepatocytes, and examples include Green Medium (described later in the literature) developed for epidermal cell culture.

長期培養維持のために、ハイドロコーチゾン、デキサメ
サゾンを加えるとよいこともあり、その他インスリン、
コレラトキシン、EGF(Epithelial growthing factor)
を加えることもある。
To maintain long-term culture, it may be advisable to add hydrocortisone, dexamethasone, other insulin,
Cholera toxin, EGF (Epithelial growthing factor)
May be added.

また、線維芽細胞の成育を抑えて肝細胞のみをよく増殖
させすために、酸素分圧を40〜50%にするのが効果的な
こともある(Y.Koganei,K.Sato,K.Nagayoshi&K.Yoshiz
ato:Proceeding of the 3rd Symposium on Cytsprotect
ion,p99.Kyoto,Jan.26,1985) さらに、温度等の培養条件は一般的なもの(例えば、
(株)リアライズ社発行「動物細胞利用実用化マニュア
ル」141〜150頁参照)を参考にすることができる。
In addition, in order to suppress the growth of fibroblasts and allow only hepatocytes to proliferate well, it is sometimes effective to set the oxygen partial pressure to 40 to 50% (Y.Koganei, K.Sato, K. Nagayoshi & K. Yoshiz
ato: Proceeding of the 3rd Symposium on Cytsprotect
ion, p99.Kyoto, Jan.26,1985) Furthermore, culture conditions such as temperature are general (for example,
Refer to "Animal Cell Utilization Manual", pages 141-150, issued by Realize Co., Ltd.).

(発明の効果) この方法を用いれば肝細胞を長期間培養維持でき、さら
に、必要に応じて肝細胞だけを分離し、採取することが
可能になり、肝細胞の機能解明に寄与するところは大き
い。
(Effect of the invention) By using this method, hepatocytes can be maintained in culture for a long period of time, and it becomes possible to separate and collect only hepatocytes as necessary, which contributes to elucidation of the function of hepatocytes. large.

本発明の方法の利用のため、細胞に親和性を有する有孔
性薄膜の両面に、それぞれ線維芽細胞と初代肝細胞を置
き、培養液を加えた肝機能試験用キットまたはこれを凍
結保存したものを予め作成しておくと便利であり、これ
らの試験用キットも本発明のうちである。また、有孔性
薄膜とX線照射した線維芽細胞を組合せて用いることも
本発明のうちである。
For use of the method of the present invention, a fibroblast and a primary hepatocyte were placed on both sides of a porous thin film having an affinity for cells, and a liver function test kit containing a culture solution or this was cryopreserved. It is convenient to prepare the test items in advance, and these test kits are also included in the present invention. It is also within the scope of the present invention to use a porous thin film in combination with X-ray irradiated fibroblasts.

以上本発明を一般的に述べてきたが、さらに実施例にて
ラット肝細胞の長期培養方法について詳細に説明する。
ただし、この実施例は本発明の具体的例示であって、本
発明を限定するものでないことは言うまでもない。
The present invention has been generally described above, and further, the method for long-term culture of rat hepatocytes will be described in detail in Examples.
However, it goes without saying that this example is a specific example of the present invention and does not limit the present invention.

実施例 (1)培養液 グリーン(H.Green)の表皮細胞における方法(N.Eng.
J.Med.,311 448−451(1984))に従って、DME(Dulbec
co′s modified Eagle Minimum Essential Medium)と
ハムのF−12培養液を3:1に混合したものに、10%牛胎
児血清(FCS)、0.4μg/mlハイドロコーチゾン、5μg/
mlインシュリン、5μg/mlトランスフェリン、2X10-9M
トリヨードチロニン、10-10Mコレラトキシン、8X10-4M
アデニンを添加して使用した。また培養4日目より10μ
g/mlEGFを添加した。
Example (1) Method for culture medium green (H. Green) epidermal cells (N. Eng.
According to J. Med., 311 448-451 (1984), DME (Dulbec
Co's modified Eagle Minimum Essential Medium) and Ham's F-12 culture medium mixed 3: 1, 10% fetal calf serum (FCS), 0.4 μg / ml hydrocortisone, 5 μg /
ml insulin, 5 μg / ml transferrin, 2X10 -9 M
Triiodothyronine, 10 -10 M cholera toxin, 8X10 -4 M
Adenine was added and used. 10μ from the 4th day of culture
g / ml EGF was added.

なお、DME、F−12培養液には10mM NaHCO3、20mM HEPE
S、100μg/mlストレプトマイシン、100units/mlペニシ
リンが含まれる。
In addition, 10 mM NaHCO 3 and 20 mM HEPE were added to the DME and F-12 culture solution.
S, 100 μg / ml streptomycin, 100 units / ml penicillin.

(2)コラーゲン薄膜の作製 コラーゲン溶液((株)高研製アテロコラーゲン、pH
3)の一定量を疎水性プラスチック上にのせ、風乾して
シート状とした後、生理食塩水中で37℃に1時間加温し
次いでUV照射した。風乾後、コラーゲンを薄膜として回
収し枠へはめこんで、細胞培養に供した。
(2) Preparation of collagen thin film Collagen solution (Koken Co., Ltd. atelocollagen, pH
A certain amount of 3) was placed on a hydrophobic plastic and air-dried to form a sheet, which was then heated in physiological saline at 37 ° C for 1 hour and then irradiated with UV. After air-drying, collagen was collected as a thin film, fitted into a frame, and subjected to cell culture.

(3)有孔性コラーゲン薄膜下面への線維芽細胞の付着 線維芽細胞は、10%FCS、10mM NaHCO3、20mM HEPES、10
0μg/mlストレプトマイシン、100units/mlペニシリンを
含むDME培養液を用いて継代培養しておいたものを、0.1
%トリプシン、1mM EDTA処理で剥離し、同培養液に分散
した。培養液中の細胞密度を6X105cells/mlに調整し、
遠心管に分注して氷水中で放射線(6000rad)を照射し
た。遠心(1500rpm,7分)により細胞を沈殿させ、上清
を同量の新鮮な培養液と交換し、再び細胞を分散した。
有孔性コラーゲン薄膜下面を上向きにして、各2mlの細
胞を含む培養液をまいた。線維芽細胞は、肝細胞をまく
まで1日間そのままで5%CO2,37℃で培養した。
(3) Attachment of fibroblasts to the lower surface of the porous collagen thin film Fibroblasts were 10% FCS, 10 mM NaHCO 3 , 20 mM HEPES, 10%.
What was subcultured using DME culture medium containing 0 μg / ml streptomycin, 100 units / ml penicillin
% Trypsin and 1 mM EDTA treatment, peeled off and dispersed in the same culture solution. Adjust the cell density in the culture to 6X10 5 cells / ml,
It was dispensed into a centrifuge tube and irradiated with radiation (6000 rad) in ice water. The cells were precipitated by centrifugation (1500 rpm, 7 minutes), the supernatant was replaced with the same amount of fresh culture medium, and the cells were dispersed again.
The lower surface of the porous collagen thin film was faced up, and a culture solution containing 2 ml of each cell was seeded. Fibroblasts were cultured for 1 day at 5% CO 2 and 37 ° C. until they were seeded.

(4)有孔性コラーゲン薄膜上へのラット肝細胞の播種 ラット(Sprague−Dawley雄、6週齢150〜200g)を用い
セグレンのコラーゲン潅流法(P.D.Seglen,Method in C
ell Biology 13,29−83頁、Academic Press(1976))
に準じて肝実細胞を調製した。得られた肝実細胞は、先
に述べたグリーンの培養液に分散し、有孔性コラーゲン
薄膜上面に2x104cells/cm2の密度になるように播いた。
培養は5%CO2、37℃でおこない、培養液の交換は週に
2回おこなった。
(4) Seeding of rat hepatocytes on a porous collagen thin film Using a rat (Sprague-Dawley male, 6-week-old 150 to 200 g), collagen perfusion method of Segren (PDSeglen, Method in C)
ell Biology 13, 29-83, Academic Press (1976))
Liver stem cells were prepared according to. The obtained liver liver cells were dispersed in the green culture solution described above and seeded on the upper surface of the porous collagen thin film at a density of 2 × 10 4 cells / cm 2 .
The culture was carried out at 37 ° C. in 5% CO 2 , and the culture medium was exchanged twice a week.

(5)肝細胞の形態と機能 コラーゲン薄膜上に接着した肝細胞は、伸展して敷石状
に並びシートを形成した。シート中には分裂像が観察さ
れ、培養2週間まで、シートは大きくなった。その後肝
細胞は、培養4週間以上著しい形態的な変化もなく維持
された。
(5) Morphology and function of hepatocytes The hepatocytes adhered to the collagen thin film were extended and arranged in a cobblestone shape to form a sheet. A mitotic image was observed in the sheet, and the sheet became large by 2 weeks of culture. Thereafter, hepatocytes were maintained for more than 4 weeks in culture without significant morphological changes.

肝細胞のアルブミンの生産を、酸素抗体法により調べた
ところ、培養4週間を通じて、肝細胞がアルブミンを生
産していることが確認された。
When the production of albumin in hepatocytes was examined by the oxygen antibody method, it was confirmed that hepatocytes produced albumin over 4 weeks of culture.

上記の長期維持に関する良好な結果はコラーゲン薄膜を
介さずに直接、線維芽細胞のフィーダー層上に肝細胞を
播種することによっても得られたが、コラーゲン薄膜を
用いた方が肝細胞の取扱等に便利である。
The above good results regarding long-term maintenance were also obtained by directly seeding hepatocytes on the feeder layer of fibroblasts without going through the collagen thin film, but using the collagen thin film is effective in handling hepatocytes, etc. It is convenient for

前記(4)で得た細胞培養物を、DMSO等の凍結保護剤と
ともに液体窒素で凍結してキット化することもできる。
The cell culture obtained in (4) above can be frozen in liquid nitrogen together with a cryoprotective agent such as DMSO to prepare a kit.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 高山 敏 東京都江戸川区北葛西1丁目16番13号 第 一製薬中央研究所内 (72)発明者 宮田 暉夫 東京都目黒区中根2丁目11番21号 日本医 用高分子材料研究所 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Satoshi Takayama 1-16-13 Kita-Kasai, Edogawa-ku, Tokyo Inside the 1st Pharmaceutical Research Center (72) Inventor Akio Miyata 2-11-21 Nakane, Meguro-ku, Tokyo No. Japan Medical Polymer Research Institute

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】細胞に親和性を有する有孔性薄膜の一方の
面に線維芽細胞をまき、かつ他方の面に肝細胞をまいて
培養することを特徴とする細胞の培養法。
1. A method for culturing cells, which comprises culturing by plating fibroblasts on one surface of a porous thin film having an affinity for cells and hepatocytes on the other surface.
【請求項2】線維芽細胞がX線照射して増殖能力を停止
させたものである特許請求の範囲第1項記載の細胞の培
養法。
2. The method for culturing cells according to claim 1, wherein the fibroblasts are irradiated with X-rays to stop their proliferation ability.
【請求項3】有孔性薄膜が有孔性コラーゲン膜である特
許請求の範囲第1項又は第2項記載の細胞の培養法。
3. The method for culturing cells according to claim 1 or 2, wherein the porous thin film is a porous collagen film.
JP61129419A 1986-06-04 1986-06-04 Cell culture method Expired - Lifetime JPH0740931B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61129419A JPH0740931B2 (en) 1986-06-04 1986-06-04 Cell culture method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61129419A JPH0740931B2 (en) 1986-06-04 1986-06-04 Cell culture method

Publications (2)

Publication Number Publication Date
JPS62285781A JPS62285781A (en) 1987-12-11
JPH0740931B2 true JPH0740931B2 (en) 1995-05-10

Family

ID=15009049

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61129419A Expired - Lifetime JPH0740931B2 (en) 1986-06-04 1986-06-04 Cell culture method

Country Status (1)

Country Link
JP (1) JPH0740931B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734016B1 (en) 1999-11-26 2004-05-11 Menicon Co., Ltd. Method for culturing cell and a culture vessel
CN111432824A (en) * 2017-09-22 2020-07-17 莱福奈特海尔斯公司 Plated hepatocytes and preparation and use thereof

Also Published As

Publication number Publication date
JPS62285781A (en) 1987-12-11

Similar Documents

Publication Publication Date Title
US6043089A (en) Skin culture and process for preparing the same
Holbrook et al. Phenotypic expression of epidermal cells in vitro: a review
CN108138098B (en) Tissue culture apparatus and method
US10413636B2 (en) Tissue scaffolds
JP3311351B2 (en) Novel keratinocyte cultures, their preparation and their use as wound healing substances
Gospodarowicz et al. The coating of bovine and rabbit corneas denuded of their endothelium with bovine corneal endothelial cells
Bullock et al. Use of human fibroblasts in the development of a xenobiotic-free culture and delivery system for human keratinocytes
HRP20040347A2 (en) Keratynocites which may be used as biologically ac
US6730513B1 (en) Keratinocyte cultures and uses thereof
EP0788381B1 (en) Biomaterial containing epithelial cells and use thereof as a transplant
US5980888A (en) Keratinocytes attached to microcarriers for treatment of skin wounds
McAuslan et al. Stimulation of endothelial cell proliferation by precursors of thymidylate
Berg et al. Comparative growth dynamics and morphology between cultured myofibroblasts from granulating wounds and dermal fibroblasts.
US6136600A (en) Method for cultivation of hepatocytes
JPWO2007080990A1 (en) Long-term maintenance of liver tissue cell function
WO2009080794A1 (en) Method for preparing cell-specific extracellular matrices
JP3738273B2 (en) Improved keratinocyte culture and use thereof
US6585969B1 (en) Non-viable keratinocyte cell composition or lysate for promoting wound healing
JP2022530620A (en) Preparation of human allogeneic liver-derived progenitor cells
JPH0740931B2 (en) Cell culture method
JP3014322B2 (en) Culture method of small hepatocytes
EP1337624B1 (en) Cell constructs which can be obtained from mesenschymal stem cells and cells derivable therefrom and the use thereof
US20090041822A1 (en) Tissue transplant construct for the reconstruction of a human or animal organ
CN114984052A (en) Application of human-derived mesenchymal stem cell membrane in treatment of uterine scar
Resau et al. Long-term culture of human esophageal explants and cells